Direct-Acting Antiviral Lowers Mortality Rate Among HCV Patients
- Direct-acting antivirals (DAA) could be the answer in treating patients with hepatitis C viral (HCV) infections, regardless of whether they also suffer from cirrhosis, according to a JAMA Network Open study. Specifically, adjusted hazard ratio of dying patients with DAA treatment and those without DAA treatment in the cirrhosis group was...
